DNDi launched its new Research & Development Strategy for Hepatitis C at the International Liver Congress (ILC) on April 13th.
|Date: April 13, 2016
The Drugs for Neglected Disease initiative announced an important agreement at the International Liver Conference in Barcelona with the Egyptian drug manufacturer Pharco to develop affordable hepatitis C regimens for the millions of people left behind the research and development revolution for hepatitis C.
For more information, please contact:
More information: ILC Website